PartsTable
Technical Data Sheet
Download PDF

NDC00338-0551-18 — DEXTROSE INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00338-0551-18: DEXTROSE INJECTION.

The DEXTROSE INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, primary_container_type: BAG, PLASTIC, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 80, primary_container_content_quantity: 100.000 MILLILITERS, active_medicament_medicinal_strength: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-384-1362, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00338-0551-18
NSN: 6505-01-384-1362
FSC: 6505 — Drugs and Biologicals
CAGE: 1G026 — BAXTER HEALTHCARE CORPORATION (USA)
SPECIFICATIONS
administrationINTRAVENOUS
special_featuresEACH MINI-BAG PLUS IS A VIAFLEX PLASTIC CONTAINER WITH AN INTEGRAL DRUG VIAL ADAPTER; AVOID EXCESSIVE HEAT; STORE AT ROOM TEMPERATURE
primary_container_typeBAG, PLASTIC
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
total_primary_container_quantity80
primary_container_content_quantity100.000 MILLILITERS
active_medicament_medicinal_strength5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyDEXTROSE INJECTION USP 100ML PLASTIC BAG
NSN6505-01-384-1362
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available DEXTROSE INJECTION TITLE COMPONENT PN NDC00338-0551-18 MFR DEXTROSE INJECTION
KEY FEATURES
•
ADMINISTRATION: INTRAVENOUS
•
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
PRIMARY CONTAINER TYPE: BAG, PLASTIC
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
•
TOTAL PRIMARY CONTAINER QUANTITY: 80
TECHNICAL CHARACTERISTICS
ADMINISTRATIONINTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY100.000 MILLILITERS
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPEBAG, PLASTIC
SPECIAL FEATURESEACH MINI-BAG PLUS IS A VIAFLEX PLASTIC CONTAINER WITH AN INTEGRAL DRUG VIAL ADAPTER; AVOID EXCESSIVE HEAT; STORE AT ROOM TEMPERATURE
PART NAME ASSIGNED BY CONTROLLING AGENCYDEXTROSE INJECTION USP 100ML PLASTIC BAG
ACTIVE MEDICAMENT MEDICINAL STRENGTH5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY80
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347
SUBSTITUTES & CROSS-REFERENCES 1
F93F129Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy NDC00338-0551-18?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00338-0551-18?
NDC00338-0551-18 is a DEXTROSE INJECTION.
What parts can replace NDC00338-0551-18?
There is 1 known substitute for NDC00338-0551-18: F93F129. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00338-0551-18?
NDC00338-0551-18 is cataloged in the U.S. Government catalog under NSN 6505-01-384-1362. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00338-0551-18